ArticleCureus2026

When Checkpoint Inhibition Goes Off Target: A Rare Case of Pembrolizumab-Induced Acalculous Cholecystitis.

Lan Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.